Argenx
ARGX
#572
Rank
$36.60 B
Marketcap
$605.87
Share price
-0.66%
Change (1 day)
33.60%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: $36.60 Billion USD

As of December 2024 Argenx has a market cap of $36.60 Billion USD. This makes Argenx the world's 572th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024$36.60 B62.21%
2023$22.56 B7.67%
2022$20.95 B13.96%
2021$18.39 B31.15%
2020$14.02 B103.85%
2019$6.87 B96.18%
2018$3.50 B74.88%
2017$2.00 B
2014$0.14 B

End of Day market cap according to different sources

On Dec 11th, 2024 the market cap of Argenx was reported to be:

$35.86 Billion USD
by Nasdaq info icon info icon
$36.72 Billion USD
by CompaniesMarketCap info icon info icon
$36.72 Billion USD
by Yahoo Finance info icon info icon